Ellen Glotzbach
Pediatrics · Kansas City, MONPI 1275647877
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $782 and has fallen 50.6% since, to $386 in 2025. Among pediatrics clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $22.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$663
- Corium, LLC$581
- Ironshore Pharmaceuticals Inc.$322
- Cranial Technologies, Inc$231
- Sanofi-aventis U.S. LLC$218
- Takeda Pharmaceuticals U.S.A., Inc.$192
- plus $992 from 18 others
What the payments were for
- Food & beverage$3,198100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 19 | $663 |
| Corium, LLC | 21 | $581 |
| Ironshore Pharmaceuticals Inc. | 12 | $322 |
| Cranial Technologies, Inc | 15 | $231 |
| Sanofi-aventis U.S. LLC | 4 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $192 |
| Pfizer | 9 | $156 |
| Sanofi Pasteur Inc. | 7 | $125 |
| Tris Pharma Inc | 8 | $124 |
| Merck | 6 | $123 |
| GSK | 7 | $103 |
| Adlon Therapeutics L.p. | 6 | $80 |
| Shire North American Group Inc | 3 | $54 |
| Sobi, Inc | 1 | $37 |
| Hologic Sales And Service, LLC | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Seqirus USA Inc | 1 | $18 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Circassia Inc. | 1 | $16 |
| Exeltis, USA Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Dermira, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$262
- TZIELD$251
- Azstarys$234
- Jornay PM 20mg capsules (Bottle of 100)$117
How this compares
$3,198 in reported general payments places this provider in the 95th percentile of 1,306 pediatrics providers in Missouri.
Other pediatrics in Kansas City
- Terri LuetjenKansas City$57K
- Sharon HumistonKansas City$41K
- Nikita RajeKansas City$23K
- Natasha BurgertKansas City$20K
- Jodi ShrobaKansas City$14K
- Rebecca FlynnKansas City$11K
- Brenda SnyderKansas City$10K
- Esosa AdahKansas City$8K
- Charles MoylanKansas City$5K
- Jordan JonesKansas City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.